Vemonis Femi, metamizole sodium, droterna hydrochloride and caffeine


Sale price £10.99 Regular price £20.00

Tax included. Shipping calculated at checkout.

Vemonis Femi x 6 tablets, metamizole sodium, droterna hydrochloride and caffeine

Vemonis Femi is an analgesic and antispasmodic drug. Such action is ensured by the active substances used in it - metamizole sodium, droterna hydrochloride and caffeine. The drug is for adults only.

Composition of Vemonis Femi, metamizole sodium, droterna hydrochloride and caffeine:

Active substances: metamizole sodium as metamizole sodium monohydrate (Metamizolum natricum), caffeine (Coffeinum), droterna hydrochloride (Drotaverini hydrochloridum). One tablet contains 400 mg metamizole sodium in the form of metamizole sodium monohydrate, 60 mg caffeine, 40 mg drotaverine hydrochloride and excipients: microcrystalline cellulose, lactose monohydrate, crospovidone, talc, magnesium stearate, shell composition: polyvinyl alcohol, titanium dioxide (E17) , xanthan gum.

Action of Vemonis Femi, metamizole sodium, droterna hydrochloride and caffeine:

The indication for the use of Vemonis Femi is severe pain. Due to its analgesic and antispasmodic effect, the drug is indicated for the symptomatic treatment of pain associated with smooth muscle spasms. It can be used for dysmenorrhea, as well as renal or intestinal colic. The drug contains a composition of three active substances. Metamizole sodium provides analgesic effect, while drotaverine hydrochloride is responsible for the relaxant effect on smooth muscles. The caffeine content helps to strengthen the analgesic effect of the drug.

Application of Vemonis Femi, metamizole sodium, droterna hydrochloride and caffeine:

The medicinal product Vemonis Femi indicated for use in the symptomatic treatment of severe pain (various types of pain) and pain associated with smooth muscle spasms, including smooth muscles of the genitourinary system - dysmenorrhea, renal colic; gastrointestinal tract - intestinal colic, irritable bowel syndrome; biliary tract - cholecystitis, cholangitis). The drug is recommended to be used when other drugs are ineffective or contraindicated. Preparation for adults.

Additional information:
The product should be stored out of reach of children at room temperature. It is recommended to protect against moisture and light. The drug contains lactose monohydrate, people with known intolerance to some sugars should discuss with the doctor the possibility of using tablets. The drug contains sodium (one tablet contains 27.6mg of sodium). During treatment, it is recommended to limit caffeine intake from other sources, as well as limit alcohol consumption.

Contraindications Vemonis Femi, metamizole sodium, droterna hydrochloride and caffeine:

Do not use in case of hypersensitivity to any component of the medicinal product (including metamizole, caffeine, drotaverine, pyrazolone derivatives (e.g. phenazone, propyphenazone) or pyrazolidine (e.g. phenylbutazone, oxyfenbutazone)). Do not use in the case of low levels of white blood cells, as well as with disturbed functioning of the bone marrow, disorders of the hematopoietic system. Do not use in asthma or intolerance resulting from taking certain drugs with analgesic effect (e.g. paracetmaol, salicylates, diclofenac, naproxen, ibuprofen, indomethacin). Do not use in cases of severe renal, hepatic or heart failure, second and third degree atrioventricular block, as well as metabolic disorders (porphyria, glucose-6-phosphate dehydrogenase deficiency), anemia. Do not use in adolescents and children under 18. age. Do not use in pregnant and lactating women.

Side effects of Vemonis Femi, metamizole sodium, droterna hydrochloride and caffeine:

There is a risk of side effects when using the drug, but they do not affect everyone. An allergic reaction requires immediate discontinuation of the drug and calling for medical help: rarely - swelling of the face, lips, tongue and / or throat, which may cause difficulty in swallowing or breathing; skin and mucosal lesions (pruritus, burning, redness, rash, hives); very rarely - severe bronchospasm; not known - anaphylactic shock (life threatening decrease in blood pressure, weakness, fainting). The occurrence of the following side effects requires stopping the drug and consulting a doctor: very rarely - pancytopenia (a significant reduction in all blood cells: red and white blood cells and platelets, general malaise, fever, signs of infection, hematomas, bleeding, pallor of the skin), agranulocytosis (complete or almost complete loss of granulocytes in the blood, manifested as: high fever, chills, sore throat, difficulty swallowing and inflammation of the cavity mucosa of the mouth, nose, throat, genitals and rectum, increased ESR, not always normal hemoglobin, erythrocytes and platelets, slightly enlarged lymph nodes and spleen. Isolated cases indicate that the risk of agranulocytosis increases when metamizole is used for more than 7 days ); hemolytic anemia, aplastic anemia, bone marrow damage, sometimes fatal. In patients with glucose-6-phosphate dehydrogenase deficiency, the drug may cause haemolysis of blood cells; decrease in the number of blood platelets (thrombocytopenia, usually manifested as increased bleeding susceptibility, the occurrence of bloody ecchymosis on the skin and mucous membranes); not known - bullous erythema multiforme - Stevens-Johnson syndrome, severe skin reactions including toxic epidermal necrolysis - Lyell's syndrome, acute generalized pustular exanthema, skin blisters (pemphigus), acute renal failure which may include the excretion of small amounts of urine (oliguria), urinary retention (anuria) or excess protein in the urine (proteinuria), acute interstitial nephritis, red urine, Kounis syndrome (acute coronary syndrome), liver damage, excessive hypotension, analgesic asthma, asthma attacks. Other side effects: uncommon - drug rash (transient rash of various types: papular, macular, pustular, erythematous); rarely - maculopapular skin lesions, leukopenia (decrease in the number of white blood cells in the blood), insomnia (associated with drotaverin), tremor, palpitations; not known - gastrointestinal disorders, peptic ulceration and bleeding, vomiting, heartburn, flatulence, nausea, abdominal pain, constipation, stomach irritation, diarrhea, dry mouth, headache and dizziness, red urine (after very high doses of metamizole ), changes in blood glucose (high and low glucose), irritability, insomnia (associated with caffeine), nervousness, anxiety, hyperactivity, increased myocardial contractility, irregular heart rhythm (arrhythmia), increased heartbeat (tachycardia) .

Dosage of Vemonis Femi, metamizole sodium, droterna hydrochloride and caffeine tablets:

Take this medicine exactly as your doctor has told you or as directed on the leaflet. Take the tablet with a sufficient amount of liquid. The dose depends on the severity of the pain and the individual response to the drug, always taking the lowest effective dose. Adults: take 1-2 tablets 2-3 times a day, but no more than every 6-8 hours. The maximum daily dose - 6 tablets. If the symptoms persist or get worse after 3-5 days of taking the medicine, you should consult your doctor.